You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Moodys
McKesson
Johnson and Johnson
Baxter

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

STROMECTOL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Stromectol patents expire, and what generic alternatives are available?

Stromectol is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in STROMECTOL is ivermectin. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ivermectin profile page.

US ANDA Litigation and Generic Entry Outlook for Stromectol

A generic version of STROMECTOL was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.

  Start Trial

Drug patent expirations by year for STROMECTOL
Drug Prices for STROMECTOL

See drug prices for STROMECTOL

Recent Clinical Trials for STROMECTOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
Clinica Universidad de Navarra, Universidad de NavarraPhase 2
Barcelona Institute for Global HealthPhase 2

See all STROMECTOL clinical trials

Pharmacology for STROMECTOL

US Patents and Regulatory Information for STROMECTOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme STROMECTOL ivermectin TABLET;ORAL 050742-002 Oct 8, 1998 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Merck Sharp Dohme STROMECTOL ivermectin TABLET;ORAL 050742-001 Nov 22, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Moodys
McKesson
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.